Mammalian diseases of phosphatidylinositol transfer proteins and their homologs

Clinical Lipidology

Volumn 5, Issue 6, 2010, Pages 867-897

  Nile, Aaron H ^a   Bankaitis, Vytas A ^a   Grabon, Aby ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

inositol signaling; lipid metabolism; phosphatidylinositol transfer protein; phosphoinositide; vertebrate disease

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL TRANSFER PROTEIN; CARRIER PROTEIN; CAYTAXIN; CELLULAR RETINOL BINDING PROTEIN 1; CHYLOMICRON; INOSITOL; KALIRIN; LIPID TRANSFER PROTEIN; LIPOPROTEIN; NEUROFIBROMIN; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; PHOSPHATIDYLINOSITOL TRANSFER PROTEIN ALPHA; PROTEIN CDC42GAP; PROTEIN DBL; PROTEIN DBS; PROTEIN DUO; PROTEIN RHOGAP; PROTEIN RHOGEF; PROTEIN SEC14; PROTEIN TRIO; PROTEIN TYROSINE PHOSPHATASE; RETINOID BINDING PROTEIN; STANDALONE SEC14 LIKE PROTEIN; UNCLASSIFIED DRUG;

ALPHA TOCOPHEROL DEFICIENCY; CEREBELLAR ATAXIA; CRYSTALLOGRAPHY; DEGENERATIVE DISEASE; ENDOSOME; FATTY LIVER; GENE MUTATION; HUMAN; LIPID METABOLISM; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MAMMALIAN DISEASE; METABOLOMICS; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; NUTRITIONAL DEFICIENCY; PANCREAS DISEASE; PATHOPHYSIOLOGY; PHOSPHOLIPID SYNTHESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EUKARYOTA; MAMMALIA; VERTEBRATA;

EID: 79952125433     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.10.67     Document Type: Review

References (222)

1. Michell RH: Inositol derivatives: evolution and functions. Nat. Rev. Mol. Biol. 9, 151-161 (2008). (Pubitemid 351158916)
2. Irivine RF: Inositide evolution - towards turtle domination? J. Physiol. 566, 295-300 (2005).
3. Fruman DA, Meyers RE, Cantley LC: Phosphoinositide kinases. Annu. Rev. Biochem. 67, 481-507 (1998). (Pubitemid 28411136)
4. Di Paolo G, De Camilli P: Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651-657 (2006). (Pubitemid 44564702)
5. Strahl T, Thorner J: Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae. Biochim. Biophys. Acta 1771, 353-404 (2007). (Pubitemid 46428617)
6. Majerus PW, York JD: Phosphoinositide phosphatases and disease. J. Lipid Res. 50, S249-S254 (2009).
7. Liu Y, Bankaitis VA: Phosphoinositide phosphatases in cell biology and disease. Prog. Lipid Res. 49, 201-217 (2010).
8. Lemmon MA: Membrane recognition by phospholipid-binding domains. Nat. Rev. Mol. Cell. Biol. 9, 99-111 (2008). (Pubitemid 351158910)
9. Balla T: Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions. J. Cell Sci. 118, 2093-2104 (2005). (Pubitemid 40872833)
10. Mclaughlin S, Murray D: Plasma membrane phosphoinositide organization by protein electrostatics. Nature 438, 605-611 (2005). (Pubitemid 41740564)
11. Routt SM, Ryan MM, Tyeryar K et al.: Nonclassical PITPs activate PLD via the Stt4p PtdIns-4-kinase and modulate function of late stages of exocytosis in vegetative yeast. Traffic 6, 1157-1172 (2005). (Pubitemid 41632267)
12. Schaaf G, Ortlund EA, Tyeryar KR et al.: Functional anatomy of phospholipid binding and regulation of phosphoinositide homeostasis by proteins of the Sec14 superfamily. Mol. Cell 29, 191-206 (2008). (Pubitemid 351172821)
13. Bankaitis VA, Mousley CJ, Schaaf G: The Sec14 superfamily and mechanisms for crosstalk between lipid metabolism and lipid signaling. Trends Biochem. Sci. 35, 150-160 (2010).
14. Wirtz KWA: Phospholipid transfer proteins. Annu. Rev. Biochem. 60, 73-99 (1991).
15. Michell RH: Inositol phospholipids and cell surface receptor function. Biochim. Biophys. Acta 415, 81-147 (1975).
16. Li X, Routt SM, Xie Z et al.: Identification of a novel family of nonclassic yeast phosphatidylinositol transfer proteins whose function modulates phospholipase D activity and Sec14p-independent cell growth. Mol. Biol. Cell 11, 1989-2005 (2000). (Pubitemid 30408059)
17. Phillips SE, Vincent P, Rizzieri KE et al.: The diverse biological functions of phosphatidylinositol transfer proteins in eukaryotes. Crit. Rev. Biochem. Mol. Biol. 41, 21-49 (2006). (Pubitemid 43214656)
18. Bankaitis VA, Malehorn DE, Emr SD, Greene R: The Saccharomyces cerevisiae SEC14 gene encodes a cytosolic factor that is required for transport of secretory proteins from the yeast Golgi complex. J. Cell Biol. 108, 1271-1281 (1989). (Pubitemid 19097036)
19. Bankaitis VA, Aitken JR, Cleves AE, Dowhan W: An essential role for a phospholipid transfer protein in yeast Golgi function. Nature 347, 561-562 (1990).
20. Yoder MD, Thomas LM, Tremblay JM et al.: Structure of a multifunctional protein: mammalian phosphatidylinositol transfer protein complexed with phosphatidylcholine. J. Biol. Chem. 276, 9246-9252 (2001).
21. Milligan SC, Alb JG, Elagina RB, Bankaitis VA, Hyde DR: The phosphatidylinositol transfer protein domain of Drosophila retinal degeneration B protein is essential for photoreceptor cell survival and recovery from light stimulation. J. Cell Biol. 139, 351-363 (1997). (Pubitemid 27459309)
22. Mousley CJ, Tyeryar K, Ile KE et al.: Trans-Golgi network and endosome dynamics connect ceramide homeostasis with regulation of the unfolded protein response and TOR signaling in yeast. Mol. Biol. Cell 19, 4785-4803 (2008).
23. Cleves AE, Novick PJ, Bankaitis VA: Mutations in the SAC1 gene suppress defects in yeast Golgi and yeast actin function. J. Cell Biol. 109, 2939-2950 (1989). (Pubitemid 20011920)
24. Cleves AE, Mcgee T, Bankaitis V: Phospholipid transfer proteins: a biological debut. Trends Cell Biol. 1, 30-34 (1991). (Pubitemid 121001658)
25. Cleves AE, Mcgee TP, Whitters EA et al.: Mutations in the CDP-choline pathway for phospholipid biosynthesis bypass the requirement for an essential phospholipid transfer protein. Cell 64, 789-800 (1991). (Pubitemid 121001166)
26. Fang M, Kearns BG, Gedvilaite A et al.: Kes1p shares homology with human oxysterol binding protein and participates in a novel regulatory pathway for yeast Golgi-derived transport vesicle biogenesis. EMBO J. 15, 6447-6459 (1996). (Pubitemid 26413778)
27. Rivas MP, Kearns BG, Xie Z et al.: Pleiotropic alterations in lipid metabolism in yeast sac1 mutants: relationship to 'bypass Sec14p' and inositol auxotrophy. Mol. Biol. Cell. 10, 2235-2250 (1999). (Pubitemid 29343132)
28. Li X, Rivas MP, Fang M et al.: Analysis of oxysterol binding protein homologue Kes1p function in regulation of Sec14p-dependent protein transport from the yeast Golgi complex. J. Cell Biol. 157, 63-77 (2002). (Pubitemid 34847830)
29. Sha B, Phillips SE, Bankaitis VA, Luo M: Crystal structure of the Saccharomyces cerevisiae phosphatidylinositol-transfer protein. Nature 391, 506-510 (1998). (Pubitemid 28086554)
30. Phillips SE, Sha B, Topalof L et al.: Yeast Sec14p deficient in phosphatidylinositol transfer activity is functional in vivo. Mol. Cell 4, 187-197 (1999). (Pubitemid 29456887)
31. Smirnova TI, Chadwick TG, Voinov MA et al.: Local polarity and hydrogen bonding inside the Sec14p phospholipid-binding cavity: high-field multi-frequency electron paramagnetic resonance studies. Biophys. J. 92, 3686-3695 (2007). (Pubitemid 46698657)
32. Ryan MM, Temple BRS, Phillips SE, Bankaitis VA: Conformational dynamics of the major yeast phosphatidylinositol transfer protein Sec14p: insight into the mechanisms of phospholipid exchange and diseases of Sec14p-like protein deficiencies. Mol. Biol. Cell 18, 1928-1942 (2007). (Pubitemid 46717572)
33. Wu W-I, Voelker DR: Biochemistry and genetics of interorganelle aminoglycerophospholipid transport. Semin. Cell Dev. Biol. 13, 185-195 (2002). (Pubitemid 35304522)
34. Holthuis JCM, Levine TP: Lipid traffic: floppy drives and a superhighway. Nat. Rev. Mol. Cell. Biol. 6, 209-220 (2005). (Pubitemid 40314922)
35. Skinner HB, Alb JG Jr, Whitters EA, Helmkamp GM Jr, Bankaitis VA: Phospholipid transfer activity is relevant to but not sufficient for the essential function of the yeast SEC14 gene product. EMBO J. 12, 4775-4784 (1993). (Pubitemid 23330283)
36. Tanaka S, Hosaka K: Cloning of a cDNA encoding a second phosphatidylinositol transfer protein of rat brain by complementation of the yeast sec14 mutation. J. Biochem 115, 981-984 (1994). (Pubitemid 24159926)
37. Ile KE, Kassen S, Cao C et al.: Zebrafish class 1 phosphatidylinositol transfer proteins: PITPb and double cone cell outer segment integrity in retina. Traffic 11, 1151-1167 (2010).
38. Mariotti C, Gellera C, Rimoldi M et al.: Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol. Sci. 25, 130-137 (2004). (Pubitemid 39136660)
39. Aparicio JM, Belanger-Quintana A, Suarez L et al.: Ataxia with isolated vitamin E deficiency: case report and review of the literature. J. Pediatr. Gastroenterol. Nutr. 33, 206-210 (2001). (Pubitemid 32802823)
40. Doria-Lamba L, De Grandis E, Cristiani E et al.: Efficacious vitamin E treatment in a child with ataxia with isolated vitamin E deficiency. Eur. J. Pediatr. 165, 494-495 (2006). (Pubitemid 43800533)
41. Yokota T, Igarashi K, Uchihara T et al.: Delayed-onset ataxia in mice lacking a-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl Acad. Sci. USA 98, 15185-15190 (2001). (Pubitemid 34013990)
42. Terasawa Y, Ladha Z, Leonard SW et al.: Increased atherosclerosis in hyperlipidemic mice deficient in a-tocopherol transfer protein and vitamin E. Proc. Natl Acad. Sci. USA 97, 13830-13834 (2000).
43. Leonard SW, Terasawa Y, Farese RV Jr, Traber MG: Incorporation of deuterated RRR- or all-rac-a-tocopherol in plasma and tissues of a-tocopherol transfer protein-null mice. Am. J. Clin. Nutr. 75, 555-560 (2002). (Pubitemid 34174951)
44. Di Donato I, Bianchi S, Federico A: Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol. Sci. 31(4), 511-515 (2010).
45. Morley S, Panagabko C, Shineman D et al.: Molecular determinants of heritable vitamin E deficiency. Biochemistry 43, 4143-4149 (2004). (Pubitemid 38445634)
46. Morley S, Cecchini M, Zhang W et al.: Mechanisms of ligand transfer by the hepatic tocopherol transfer protein. J. Biol. Chem. 283, 17797-17804 (2008).
47. Qian J, Atkinson J, Manor D: Biochemical consequences of heritable mutations in the a-tocopherol transfer protein. Biochemistry 45, 8236-8242 (2006). (Pubitemid 44036529)
48. Akihiro H, Makoto A, Yuji S et al.: Affinity for a-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 409, 105-108 (1997).
49. Panagabko C, Morley S, Hernandez M et al.: Ligand specificity in the CRAL-TRIO protein family. Biochemistry 42, 6467-6474 (2003). (Pubitemid 36665821)
50. Zhang W, Frahm G, Morley S, Manor D, Atkinson J: Effect of bilayer phospholipid composition and curvature on ligand transfer by the a-tocopherol transfer protein. Lipids 44, 631-641 (2009).
51. Traber MG: Vitamin E regulatory mechanisms. Annu. Rev. Nutr. 27, 347-362 (2007). (Pubitemid 351373361)
52. Clarke MW, Burnett JR, Croft KD: Vitamin E in human health and disease. Crit. Rev. Clin. Lab. Sci. 45, 417-450 (2008).
53. Horiguchi M, Arita M, Kaempf-Rotzoll DE et al.: pH-dependent translocation of a-tocopherol transfer protein (a-TTP) between hepatic cytosol and late endosomes. Genes Cells 8, 789-800 (2003). (Pubitemid 37304355)
54. Qian J, Morley S, Wilson K et al.: Intracellular trafficking of vitamin E in hepatocytes: the role of tocopherol transfer protein. J. Lipid Res. 46, 2072-2082 (2005) (Pubitemid 41377459)
55. Arita M, Nomura K, Arai H, Inoue K: a-Tocopherol transfer protein stimulates the secretion of a-tocopherol from a cultured liver cell line through a brefeldin A-insensitive pathway. Proc. Natl Acad. Sci. USA 94, 12437-12441 (1997). (Pubitemid 27492546)
56. Bomar JM, Benke PJ, Slattery EL et al.: Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. Nat. Genet. 35, 264-269 (2003). (Pubitemid 37363181)
57. Nystuen A, Benke PJ, Merren J, Stone EM, Sheffield VC: A cerebellar ataxia locus identified by DNA pooling to search for linkage disequilibrium in an isolated population from the Cayman Islands. Hum. Mol. Genet. 5, 525-531 (1996). (Pubitemid 26101149)
58. Xiao J, Gong S, Ledoux MS: Caytaxin deficiency disrupts signaling pathways in cerebellar cortex. Neuroscience 144, 439-461 (2007). (Pubitemid 44856755)
59. Xiao J, Ledoux MS: Caytaxin deficiency causes generalized dystonia in rats. Mol. Brain Res. 141, 181-192 (2005). (Pubitemid 41608700)
60. Ledoux MS, Lorden JF: Abnormal spontaneous and harmaline-stimulated Purkinje cell activity in the awake genetically dystonic rat. Exp. Brain Res. 145, 457-467 (2002). (Pubitemid 34994788)
61. Martins-De-Souza D, Gattaz W, Schmitt A et al.: Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur. Arch. Psychiatry. Clin. Neurosci. 259, 151-163 (2009).
62. Ledoux MS, Lorden JF, Ervin JM: Cerebellectomy eliminates the motor syndrome of the genetically dystonic rat. Exp. Neurol. 120, 302-310 (1993). (Pubitemid 23165024)
63. Ledoux MS, Lorden JF, Meinzen-Derr J: Selective elimination of cerebellar output in the genetically dystonic rat. Brain Res. 697, 91-103 (1995).
64. Raike RS, Jinnah HA, Hess EJ: Animal models of generalized dystonia. NeuroRx 2, 504-512 (2005). (Pubitemid 41444884)
65. Grelle G, Kostka S, Otto A et al.: Identification of VCP/p97, carboxyl terminus of Hsp70-interacting protein (CHIP), and amphiphysin II Interaction partners using membrane-based human proteome arrays. Mol. Cell Proteomics 5, 234-244 (2006). (Pubitemid 43329302)
66. Buschdorf JP, Chew LL, Soh UJK, Liou Y-C, Low BC: Nerve growth factor stimulates interaction of cayman ataxia protein BNIP-H/Caytaxin with peptidyl-prolyl isomerase Pin1 in differentiating neurons. PLoS One 3, E2686 (2008).
67. Hayakawa Y, Itoh M, Yamada A, Mitsuda T, Nakagawa T: Expression and localization of Cayman ataxia-related protein, Caytaxin, is regulated in a developmental- and spatial-dependent manner. Brain Res. 1129, 100-109 (2007). (Pubitemid 46048773)
68. Aoyama T, Hata S, Nakao T et al.: Cayman ataxia protein caytaxin is transported by kinesin along neurites through binding to kinesin light chains. J. Cell Sci. 122, 4177-4185 (2009).
69. Travis GH, Golczak M, Moise AR, Palczewski K: Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents. Annu. Rev. Pharmacol. Toxicol. 47, 469-512 (2007).
70. Thompson DA, Gal A: Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases. Prog. Retin. Eye. Res. 22, 683-703 (2003). (Pubitemid 36936806)
71. Saari JC, Crabb JW: Focus on molecules: cellular retinaldehyde-binding protein (CRALBP). Exp. Eye Res. 81, 245-246 (2005). (Pubitemid 41208159)
72. Saari JC, Nawrot M, Kennedy BN et al.: Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation. Neuron 29, 739-748 (2001). (Pubitemid 32323946)
73. Stecher H, Gelb MH, Saari JC, Palczewski K: Preferential release of 11-cis-retinol from retinal pigment epithelial cells in the presence of cellular retinaldehyde-binding protein. J. Biol. Chem. 274, 8577-8585 (1999). (Pubitemid 29164649)
74. Saari JC, Bredberg DL, Noy N: Control of substrate flow at a branch in the visual cycle. Biochemistry 33, 3106-3112 (1994). (Pubitemid 24103374)
75. Nawrot M, West K, Huang J et al.: Cellular retinaldehyde-binding protein interacts with ERM-binding phosphoprotein 50 in retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 45, 393-401 (2004). (Pubitemid 38140494)
76. Saari JC, Nawrot M, Stenkamp RE, Teller DC, Garwin GG: Release of 11-cis-retinal from cellular retinaldehyde-binding protein by acidic lipids. Mol. Vis. 15, 844-854 (2009).
77. Golovleva I, Bhattacharya S, Wu Z et al.: Disease-causing mutations in the cellular retinaldehyde binding protein tighten and abolish ligand interactions. J. Biol. Chem. 278, 12397-12402 (2003). (Pubitemid 36800225)
78. Maw MA, Kennedy B, Knight A et al.: Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa. Nat. Genet. 17, 198-200 (1997).
79. Golovleva I, Köhn L, Burstedt M, Daiger S, Sandgren O: Mutation spectra in autosomal dominant and recessive retinitis pigmentosa in Northern Sweden. Adv. Exp. Med. Biol. 664, 255-262 (2010).
80. Burstedt M, Sandgren O, Holmgren G, Forsman-Semb K: Bothnia dystrophy caused by mutations in the cellular retinaldehyde-binding protein gene (RLBP1) on chromosome 15q26. Invest. Ophthalmol. Vis. Sci. 40, 995-1000 (1999). (Pubitemid 29153267)
81. He X, Lobsiger J, Stocker A: Bothnia dystrophy is caused by domino-like rearrangements in cellular retinaldehyde-binding protein mutant R234W. Proc. Natl Acad. Sci. USA 106, 18545-18550 (2009).
82. Deeg CA, Raith AJ, Amann B et al.: CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin. Dev. Immunol. 2007, 39245 (2007).
83. Treadwell JA, Pagniello KB, Singh SM: Genetic segregation of brain gene expression identifies retinaldehyde binding protein 1 and syntaxin 12 as potential contributors to ethanol preference in mice. Behav. Genet. 34, 425-439 (2004). (Pubitemid 38987976)
84. Curwin AJ, Mcmaster CR: Structure and function of the enigmatic Sec14 domain-containing proteins and the etiology of human disease. Future Lipidol. 3, 399-410 (2008).
85. Zhang HM, Cheung P, Yanagawa B, Mcmanus BM, Yang DC: BNips: a group of proapoptotic proteins in the Bcl-2 family. Apoptosis 8, 229-236 (2003). (Pubitemid 36749608)
86. García-Mata R, Burridge K: Catching a GEF by its tail. Trends Cell Biol. 17, 36-43 (2007). (Pubitemid 46039879)
87. Rossman KL, Der CJ, Sondek J: GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell. Biol. 6, 167-180 (2005). (Pubitemid 40215811)
88. Kostenko EV, Mahon GM, Cheng L, Whitehead IP: The Sec14 homology domain regulates the cellular distribution and transforming activity of the Rho-specific guanine nucleotide exchange factor Dbs. J. Biol. Chem. 280, 2807-2817 (2005). (Pubitemid 40189388)
89. Ueda S, Kataoka T, Satoh T: Role of the Sec14-like domain of Dbl family exchange factors in the regulation of Rho family GTPases in different subcellular sites. Cell. Signal. 16, 899-906 (2004). (Pubitemid 38638780)
90. Johnson RC, Penzes P, Eipper BA, Mains RE: Isoforms of Kalirin, a neuronal Dbl family member, generated through use of different 5′- and 3′-ends along with an internal translational initiation site. J. Biol. Chem. 275, 19324-19333 (2000). (Pubitemid 30422906)
91. Portales-Casamar E, Briañon-Marjollet A, Fromont S, Triboulet R, Debant A: Identification of novel neuronal isoforms of the Rho-GEF Trio. Biol. Cell 98, 183-193 (2006). (Pubitemid 43336810)
92. Komai K, Mukae-Sakairi N, Kitagawa M, Shiozawa S: Characterization of novel splicing variants of the mouse MCF-2 (DBL) proto-oncogene. Biochem. Biophys. Res. Commun. 309, 906-909 (2003). (Pubitemid 37122615)
93. Vanni C, Mancini P, Gao Y et al.: Regulation of proto-Dbl by intracellular membrane targeting and protein stability. J. Biol. Chem. 277, 19745-19753 (2002). (Pubitemid 34967490)
94. Fardin P, Ognibene M, Vanni C et al.: Induction of epithelial mesenchimal transition and vasculogenesis in the lenses of Dbl oncogene transgenic mice. PLoS One 4, E7058 (2009).
95. Hirsch E, Pozzato M, Vercelli A et al.: Defective dendrite elongation but normal fertility in mice lacking the Rho-Like GTPase activator Dbl. Mol. Cell. Biol. 22, 3140-3148 (2002). (Pubitemid 34437472)
96. Mcpherson CE, Eipper BA, Mains RE: Genomic organization and differential expression of Kalirin isoforms. Gene 284, 41-51 (2002). (Pubitemid 34219399)
97. Rabiner CA, Mains RE, Eipper BA: Kalirin: a dual Rho guanine nucleotide exchange factor that is so much more than the sum of its many parts. Neuroscientist 11, 148-160 (2005). (Pubitemid 40388497)
98. Schiller MR, Ferraro F, Wang Y et al.: Autonomous functions for the Sec14p/spectrin-repeat region of Kalirin. Exp. Cell Res. 314, 2674-2691 (2008).
99. Penzes P, Johnson RC, Sattler R et al.: The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain containing proteins and regulates dendritic morphogenesis. Neuron 29, 229-242 (2001). (Pubitemid 32108735)
100. Cahill ME, Xie Z, Day M et al.: Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc. Natl Acad. Sci. USA 106, 13058-13063 (2009).
101. Xie Z, Cahill ME, Penzes P: Kalirin loss results in cortical morphological alterations. Mol. Cell Neurosci. 43, 81-89 (2010).
102. Krug T, Manso H, Gouveia L et al.: Kalirin: a novel genetic risk factor for ischemic stroke. Hum. Genet. 127, 513-523 (2010).
103. Wang L, Hauser ER, Shah SH et al.: Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am. J. Hum. Genet. 80, 650-663 (2007). (Pubitemid 46564402)
104. Youn H, Ji I, Ji HP, Markesbery WR, Ji TH: Under-expression of Kalirin-7 increases iNOS activity in cultured cells and correlates to elevated iNOS activity in Alzheimer's disease hippocampus. J. Alzheimers Dis. 12, 271-281 (2007).
105. Hayashi-Takagi A, Takaki M, Graziane N et al.: Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327-332 (2010).
106. Penzes P, Jones KA: Dendritic spine dynamics - a key role for kalirin-7. Trends Neurosci. 31, 419-427 (2008).
107. Saneyoshi T, Fortin DA, Soderling TR: Regulation of spine and synapse formation by activity-dependent intracellular signaling pathways. Curr. Opin. Neurobiol. 20, 108-115 (2010).
108. Xie Z, Srivastava DP, Photowala H et al.: Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron 56, 640-656 (2007). (Pubitemid 350102031)
109. Nishida K, Kaziro Y, Satoh T: Association of the proto-oncogene product Dbl with G protein bg subunits. FEBS Lett. 459, 186-190 (1999). (Pubitemid 29475027)
110. Briancon-Marjollet A, Ghogha A, Nawabi H et al.: Trio mediates Netrin-1-induced Rac1 activation in axon outgrowth and guidance. Mol. Cell. Biol. 28, 2314-2323 (2008). (Pubitemid 351429977)
111. O'Brien SP, Seipel K, Medley QG et al.: Skeletal muscle deformity and neuronal disorder in Trio exchange factor-deficient mouse embryos. Proc. Natl Acad. Sci. USA 97, 12074-12078 (2000).
112. Zheng M, Simon R, Mirlacher M et al.: TRIO amplification and abundant mRNA expression Is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Am. J. Pathol. 165, 63-69 (2004). (Pubitemid 38821814)
113. Chattopadhyay I, Singh A, Phukan R et al.: Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India. Mutat. Res. 696, 130-138 (2010).
114. Sun Y-J, Nishikawa K, Yuda H et al.: Solo/Trio8, a membrane-associated short isoform of Trio, modulates endosome dynamics and neurite elongation. Mol. Cell. Biol. 26, 6923-6935 (2006). (Pubitemid 44387641)
115. Estrach S, Schmidt S, Diriong S et al.: The human Rho-GEF Trio and Its target GTPase RhoG are involved in the NGF pathway, leading to neurite outgrowth. Curr. Biol. 12, 307-312 (2002). (Pubitemid 34161475)
116. Liu Z, Adams HC, Whitehead IP: The Rho-specific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration. J. Biol. Chem. 284, 15771-15780 (2009).
117. Tcherkezian J, Lamarche-Vane N: Current knowledge of the large RhoGAP family of proteins. Biol. Cell 099, 67-86 (2007). (Pubitemid 46242033)
118. Wang L, Yang L, Debidda M, Witte D, Zheng Y: Cdc42 GTPase-activating protein deficiency promotes genomic instability and premature aging-like phenotypes. Proc. Natl Acad. Sci. USA 104, 1248-1253 (2007). (Pubitemid 46183990)
119. Wang L, Yang L, Burns K, Kuan C-Y, Zheng Y: Cdc42GAP regulates c-Jun N-terminal kinase (JNK)-mediated apoptosis and cell number during mammalian perinatal growth. Proc. Natl Acad. Sci. USA 102, 13484-13489 (2005). (Pubitemid 41420874)
120. Yang L, Wang L, Zheng Y: Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts. Mol. Biol. Cell 17, 4675-4685 (2006). (Pubitemid 44665738)
121. Hatjiharissi E, Ngo H, Leontovich AA et al.: Proteomic analysis of waldenstrom macroglobulinemia. Cancer Res. 67, 3777-3784 (2007). (Pubitemid 46762164)
122. Jin L, Liu G, Zhang C-H et al.: Nm23-H1 regulates the proliferation and differentiation of the human chronic myeloid leukemia K562 cell line: a functional proteomics study. Life Sci. 84, 458-467 (2009).
123. Engelse M, Laurens N, Verloop R, Koolwijk P, Van Hinsbergh V: Differential gene expression analysis of tubule forming and non-tubule forming endothelial cells: CDC42GAP as a counter-regulator in tubule formation. Angiogenesis 11, 153-167 (2008).
124. Sirokmány G, Szidonya L, Káldi K et al.: Sec14 homology domain targets p50RhoGAP to endosomes and provides a link between Rab and Rho GTPases. J. Biol. Chem. 281, 6096-6105 (2006). (Pubitemid 43847711)
125. Moskwa P, Paclet M-H, Dagher M-C, Ligeti E: Autoinhibition of p50 Rho GTPase-activating protein (GAP) is released by prenylated small GTPases. J. Biol. Chem. 280, 6716-6720 (2005). (Pubitemid 40341226)
126. Cichowski K, Jacks T: NF1 tumor suppressor gene function: narrowing the GAP. Cell 104, 593-604 (2001). (Pubitemid 32201953)
127. D'Angelo I, Welti S, Bonneau F, Scheffzek K: A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep. 7, 174-179 (2006).
128. Friedman JM: Epidemiology of neurofibromatosis type 1. Am. J. Med. Genet. 89, 1-6 (1999). (Pubitemid 30033170)
129. Ferner RE, Huson SM, Thomas N et al.: Guidelines for the diagnosis and management of individuals with neurofibromatosis-1. J. Med. Genet. 44, 81-88 (2007).
130. Gottfried ON, Viskochil DH, Couldwell WT: Neurofibromatosis type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Neurosurg. Focus 28, E8 (2010).
131. Xu G, O'Connell P, Viskochil D et al.: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599-608 (1990).
132. Aravind L, Neuwald AF, Ponting CP: Sec14p-like domains in NF1 and Dbl-like proteins indicate lipid regulation of Ras and Rho signaling. Curr. Biol. 9, R195-R197 (1999). (Pubitemid 29181825)
133. Bonneau F, Lenherr ED, Pena V, Hart DJ, Scheffzek K: Solubility survey of fragments of the neurofibromatosis type 1 protein neurofibromin. Protein Expr. Purif. 65, 30-37 (2009).
134. Fahsold R, Hoffmeyer S, Mischung C et al.: Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am. J. Hum. Genet. 66, 790-818 (2000). (Pubitemid 30470484)
135. Upadhyaya M, Maynard J, Osborn M et al.: Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene. J. Med. Genet. 32, 706-710 (1995).
136. Welti S, Fraterman S, D'angelo I, Wilm M, Scheffzek K: The Sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex. J. Mol. Biol. 366, 551-562 (2007). (Pubitemid 46136212)
137. Huynh H, Wang X, Li W et al.: Homotypic secretory vesicle fusion induced by the protein tyrosine phosphatase MEG2 depends on polyphosphoinositides in T cells. J. Immunol. 171, 6661-6671 (2003). (Pubitemid 37532098)
138. Alonso A, Sasin J, Bottini N et al.: Protein tyrosine phosphatases in the human genome. Cell 117, 699-711 (2004). (Pubitemid 38748887)
139. Saito K, Tautz L, Mustelin T: The lipid-binding SEC14 domain. Biochim. Biophys. Acta 1771, 719-726 (2007). (Pubitemid 46856890)
140. Kruger JM, Fukushima T, Cherepanov V et al.: Protein-tyrosine phosphatase MEG2 is expressed by human neutrophils. J. Biol. Chem. 277, 2620-2628 (2002).
141. Zhao R, Fu X, Li Q, Krantz SB, Zhao ZJ: Tyrosine phosphatase MEG2 modulates murine development and platelet and lymphocyte activation through secretory vesicle function. J. Exp. Med. 202, 1587-1597 (2005).
142. Huynh H, Bottini N, Williams S et al.: Control of vesicle fusion by a tyrosine phosphatase. Nat. Cell Biol. 6, 831-839 (2004). (Pubitemid 39207248)
143. Saito K, Williams S, Bulankina A, Höning S, Mustelin T: Association of protein-tyrosine phosphatase MEG2 via its Sec14p homology domain with vesicle-trafficking proteins. J. Biol. Chem. 282, 15170-15178 (2007). (Pubitemid 47093384)
144. Phillips SE, Ile KE, Boukhelifa M, Huijbregts RPH, Bankaitis VA: Specific and nonspecific membrane-binding determinants cooperate in targeting phosphatidylinositol transfer protein b-isoform to the mammalian trans-Golgi network. Mol. Biol. Cell 17, 2498-2512 (2006). (Pubitemid 43825489)
145. Morgan CP, Allen-Baume V, Radulovic M et al.: Differential expression of a C-terminal splice variant of phosphatidylinositol transfer protein b lacking the constitutive-phosphorylated Ser262 that localizes to the Golgi compartment. Biochem. J. 398, 411-421 (2006). (Pubitemid 44453385)
146. Schouten A, Agianian B, Westerman J et al.: Structure of apo-phosphatidylinositol transfer protein-a provides insight into membrane association. EMBO J. 21, 2117-2121 (2002). (Pubitemid 34516770)
147. Tilley SJ, Skippen A, Murray-Rust J et al.: Structure-function analysis of phosphatidylinositol transfer protein A bound to human phosphatidylinositol. Structure 12, 317-326 (2004). (Pubitemid 38224554)
148. Alb JG Jr, Phillips SE, Rostand K et al.: Genetic ablation of phosphatidylinositol transfer protein function in murine embryonic stem cells. Mol. Biol. Cell 13, 739-754 (2002). (Pubitemid 34250343)
149. Hay JC, Martin TF: Phosphatidylinositol transfer protein required for ATP-dependent priming of Ca2+-activated secretion. Nature 374, 173-177 (1995).
150. Ohashi M, Jan De Vries K, Frank R et al.: A role for phosphatidylinositol transfer protein in secretory vesicle formation. Nature 377, 544-547 (1995).
151. Thomas GMH, Cunningham E, Fensome A et al.: An essential role for phosphatidylinositol transfer protein in phospholipase C-mediated inositol lipid signaling. Cell 74, 919-928 (1993). (Pubitemid 23270611)
152. Xie Y, Ding YQ, Hong Y et al.: Phosphatidylinositol transfer protein-iiin netrin-1-induced PLC signalling and neurite outgrowth. Nat. Cell Biol. 7, 1124-1132 (2005).
153. Kauffmann-Zeh A, Thomas G, Ball A: Requirement for phosphatidylinositol transfer protein in epidermal growth factor signaling. Science 268, 1188-1190 (1995).
154. Carvou N, Holic R, Li M et al.: Phosphatidylinositol- and phosphatidylcholine-transfer activity of PITPb is essential for COPI-mediated retrograde transport from the Golgi to the endoplasmic reticulum. J. Cell Sci. 123, 1262-1273 (2010).
155. Weimar WR, Lane PW, Sidman RL: Vibrator (vb): a spinocerebellar system degeneration with autosomal recessive inheritance in mice. Brain Res. 251, 357-364 (1982). (Pubitemid 13230312)
156. Hamilton BA, Smith DJ, Mueller KL et al.: The vibrator mutation causes neurodegeneration via reduced expression of PITPa: positional complementation cloning and extragenic suppression. Neuron 18, 711-722 (1997). (Pubitemid 27232783)
157. Alb JG, Phillips SE, Wilfley LR, Philpot BD, Bankaitis VA: The pathologies associated with functional titration of phosphatidylinositol transfer protein a activity in mice. J. Lipid Res. 48, 1857-1872 (2007). (Pubitemid 47312001)
158. Alb JGJ, Cortese JD, Phillips SE et al.: Mice lacking phosphatidylinositol transfer protein-a exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia. J. Biol. Chem. 278, 33501-33518 (2003). (Pubitemid 37055805)
159. Nyquist DA, Helmkamp GMJ: Developmental patterns in rat brain of phosphatidylinositol synthetic enzymes and phosphatidylinositol transfer protein. Biochim. Biophys. Acta. 987, 165-170 (1989). (Pubitemid 20016461)
160. Utsunomiya A, Owada Y, Yoshimoto T, Kondo H: Localization of gene expression for phosphatidylinositol transfer protein in the brain of developing and mature rats. Mol. Brain Res. 45, 349-352 (1997). (Pubitemid 27170715)
161. Imai H, Tanaka S, Fukusato T, Yamashita S, Hosaka K: Differential distribution of mRNAs encoding phosphatidylinositol transfer proteins a and b in the central nervous system of the rat. Mol. Brain Res. 46, 256-264 (1997). (Pubitemid 27218308)
162. Floyd JA, Gold DA, Concepcion D et al.: A natural allele of Nxf1 suppresses retrovirus insertional mutations. Nat. Genet. 35, 221-228 (2003). (Pubitemid 37363175)
163. Elble RJ: Central mechanisms of tremor. J. Clin. Neurophysiol. 13, 133-144 (1996). (Pubitemid 26069277)
164. Gauthier S, Sniderman A: Action tremor as a manifestation of chylomicron retention disease. Ann. Neurol. 14, 591 (1983). (Pubitemid 14239731)
165. Trapp BD, Nave K-A: Multiple sclerosis: an immune or neurodegenerative disorder? Ann. Rev. Neurosci. 31, 247-269 (2008).
166. Schwab C, Mcgeer PL: Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J. Alzheimers Dis. 13, 359-369 (2008). (Pubitemid 352039027)
167. Bunte H, Schenning M, Sodaar P et al.: A phosphatidylinositol transfer protein a-dependent survival factor protects cultured primary neurons against serum deprivation-induced cell death. J. Neurochem. 97, 707-715 (2006).
168. Fazeli A, Dickinson SL, Hermiston ML et al.: Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature 386, 796-804 (1997). (Pubitemid 27181247)
169. Serafini T, Colamarino SA, Leonardo ED et al.: Netrin-1 Is required for commissural axon guidance in the developing vertebrate nervous system. Cell 87, 1001-1014 (1996). (Pubitemid 26427984)
170. Cosker KE, Shadan S, Van Diepen M et al.: Regulation of PI3K signalling by the phosphatidylinositol transfer protein PITPa during axonal extension in hippocampal neurons. J. Cell Sci. 121, 796-803 (2008). (Pubitemid 351578115)
171. Finger JH, Bronson RT, Harris B et al.: The netrin 1 receptors Unc5h3 and Dcc are necessary at multiple choice points for the guidance of corticospinal tract axons. J. Neurosci. 22, 10346-10356 (2002). (Pubitemid 35416872)
172. Jones SM, Kazlauskas A: Growth factor-dependent signaling and cell cycle progression. Chem. Rev. 101, 2413-2424 (2001).
173. Luetteke NC, Phillips HK, Qiu TH et al.: The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8, 399-413 (1994). (Pubitemid 24071181)
174. Miettinen PJ, Berger JE, Meneses J et al.: Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376, 337-341 (1995).
175. Sibilia M, Wagner EF: Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269, 234-238 (1995).
176. Charcosset M, Sassolas A, Peretti N et al.: Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein. Mol. Genet. Metab. 93, 74-84 (2008). (Pubitemid 350245616)
177. Jones B, Jones EL, Bonney SA et al.: Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat. Genet. 34, 29-31 (2003). (Pubitemid 36548786)
178. Miller EA, Barlowe C: Regulation of coat assembly-sorting things out at the ER. Curr. Opin. Cell Biol. 22(4), 447-453 (2001).
179. D'angelo G, Vicinanza M, Di Campli A, De Matteis MA: The multiple roles of PtdIns(4)P - not just the precursor of PtdIns(4,5)P2. J. Cell Sci. 121, 1955-1963 (2008). (Pubitemid 352015192)
180. Blumental-Perry A, Haney CJ, Weixel Kelly M et al.: Phosphatidylinositol 4-phosphate formation at ER exit sites regulates ER export. Dev. Cell 11, 671-682 (2006). (Pubitemid 44644961)
181. Monaco ME, Kim J, Ruan W et al.: Lipid metabolism in phosphatidylinositol transfer protein a-deficient vibrator mice. Biochem. Biophys. Res. Commun. 317, 444-450 (2004). (Pubitemid 38452503)
182. Hayashi E, Maeda T, Tomita T: The effect of myo-inositol deficiency on lipid metabolism in rats. I. The alteration of lipid metabolism in myo-inositol deficient rats. Biochim. Biophys. Acta. 360, 134-145 (1974).
183. Burton LE, Wells WW: Myo-inositol metabolism during lactation and development in the rat. The prevention of lactation-induced fatty liver by dietary myo-inositol. J. Nutr. 106, 1617-1628 (1976).
184. Burton LE, Wells WW: Characterization of the lactation-dependent fatty liver in myo-inositol deficient rats. J. Nutr. 107, 1871-1883 (1977). (Pubitemid 8206377)
185. Hayashi E, Maeda T, Tomita T: The effect of myo-inositol deficiency on lipid metabolism in rats. II. The mechanism of triacylglycerol accumulation in the liver of myo-inositol-deficient rats. J. Nutr. 360, 146-155 (1974).
186. Burton LE, Wells WW: Myo-inositol deficiency: studies on the mechanism of lactation-dependent fatty liver formation in the rat. J. Nutr. 109, 1483-1491 (1979). (Pubitemid 9241707)
187. Kroes JF, Hegsted DM, Hayes KC: Inositol deficiency in gerbils: dietary effects on the intestinal lipodystrophy. J. Nutr. 103, 1448-1453 (1973).
188. Woods MN, Hegsted DM: Quantitative and qualitative changes in phospholipid in the intestine of the gerbil and the development of lipodystrophy. J. Nutr. 109, 2146-2151 (1979). (Pubitemid 10180518)
189. Chu SH, Hegsted DM: Myo-inositol deficiency in gerbils: changes in phospholipid composition of intestinal microsomes. J. Nutr. 110, 1217-1223 (1980). (Pubitemid 10062725)
190. Chu SH, Hegsted DM: Myo-inositol deficiency in gerbils: comparative study of the intestinal lipodystrophy in Meriones unguiculatus and Meriones libycus. J. Nutr. 110, 1209-1216 (1980). (Pubitemid 10062724)
191. Chu SW, Geyer RP: Myo-inositol action on gerbil intestine. Association of phosphatidylinositol metabolism with lipid clearance. Biochim. Biophys. Acta. 710, 63-70 (1982). (Pubitemid 12141263)
192. Young RW: Biogenesis and renewal of visual cell outer segment membranes. Exp. Eye Res. 18, 215-223 (1974).
193. Chuang JZ, Zhao Y, Sung C-H: SARA-regulated vesicular targeting underlies formation of the light-sensing organelle in mammalian rods. Cell 130, 535-547 (2007). (Pubitemid 47198304)
194. Boyd JM, Malstrom S, Subramanian T et al.: Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79, 341-351 (1994). (Pubitemid 24324923)
195. Sall A, Zhang HM, Qiu D et al.: Proapoptotic activity of mBNIP-21 depends on its BNIP-2 and Cdc42GAP homology (BCH) domain and is enhanced by coxsackievirus B3 infection. Cell Microbiol. 12(5), 599-614 (2010).
196. Zhou YT, Guy GR, Low BC: BNIP-2 induces cell elongation and membrane protrusions by interacting with Cdc42 via a unique Cdc42-binding motif within its BNIP-2 and Cdc42GAP homology domain. Exp. Cell Res. 303, 263-274 (2005). (Pubitemid 40126261)
197. Qin W, Hu J, Guo M et al.: BNIPL-2, a novel homologue of BNIP-2, interacts with Bcl-2 and Cdc42GAP in apoptosis. Biochem. Biophys. Res. Commun. 308, 379-385 (2003). (Pubitemid 36939186)
198. Xie L, Qin W, Li J et al.: BNIPL-2 promotes the invasion and metastasis of human hepatocellular carcinoma cells. Oncol. Rep. 17, 605-610 (2007).
199. Machida T, Fujita T, Ooo ML et al.: Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas. Oncogene 25, 1931-1942 (2005).
200. Clarke RA, Zhao Z, Guo A-Y et al.: New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression. PLoS ONE 4, E4995 (2009).
201. Valencia CA, Cotten SW, Liu R: Cleavage of BNIP-2 and BNIP-XL by caspases. Biochem. Biophys. Res. Commun. 364, 495-501 (2007). (Pubitemid 350026494)
202. Soh UJK, Low BC: BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain. J. Cell Sci. 121, 1739-1749 (2008). (Pubitemid 351911830)
203. Johnstone CN, Castellví-Bel S, Chang LM et al.: ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers. Gene 336, 59-71 (2004). (Pubitemid 38968825)
204. Lua BL, Low BC: Activation of EGF receptor endocytosis and ERK1/2 signaling by BPGAP1 requires direct interaction with EEN/endophilin II and a functional RhoGAP domain. J. Cell Sci. 118, 2707-2721 (2005). (Pubitemid 40932895)
205. Lua BL, Low BC: BPGAP1 interacts with cortactin and facilitates its translocation to cell periphery for enhanced cell migration. Mol. Biol. Cell 15, 2873-2883 (2004). (Pubitemid 38691875)
206. Song JY, Lee JK, Lee NW et al.: Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer. Int. J. Gynecol. Cancer. 18, 1051-1059 (2008).
207. Shang X, Zhou YT, Low BC: Concerted regulation of cell dynamics by BNIP-2 and Cdc42GAP homology/Sec14p-like, proline-rich, and GTPase-activating protein domains of a novel Rho GTPase-activating protein, BPGAP1. J. Biol. Chem. 278, 45903-45914 (2003). (Pubitemid 37432736)
208. Kong YH, Ye GM, Qu K et al.: Cloning and characterization of a novel, human cellular retinaldehyde-binding protein CRALBP-like (CRALBPL) gene. Biotechnol. Lett. 28, 1327-1333 (2006).
209. Zhao S, Xu C, Qian H et al.: Cellular retinaldehyde-binding protein-like (CRALBPL), a novel human Sec14p-like gene that is upregulated in human hepatocellular carcinomas, may be used as a marker for human hepatocellular carcinomas. DNA Cell Biol. 27, 159-163 (2008). (Pubitemid 351457768)
210. Katoh Y, Ritter B, Gaffry T et al.: The Clavesin family, neuron-specific lipid-and clathrin-binding Sec14 proteins regulating lysosomal morphology. J. Biol. Chem. 284, 27646-27654 (2009).
211. Ribeiro FM, Ferreira LT, Marion S et al.: SEC14-like protein 1 interacts with cholinergic transporters. Neurochem. Int. 50, 356-364 (2007). (Pubitemid 46097166)
212. Wang X, Ni J, Hsu CL et al.: Reduced expression of tocopherol-associated protein (TAP/Sec14L2) in human breast cancer. Cancer Invest. 27, 971-977 (2009).
213. Johnykutty S, Tang P, Zhao H et al.: Dual expression of a-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of a-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas. Mod. Pathol. 22, 770-775 (2009).
214. Shibata N, Jishage KI, Arita M et al.: Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesis. FASEB J. 20, 2642-2644 (2006).
215. Ni J, Wen X, Yao J et al.: Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res. 65, 9807-9816 (2005). (Pubitemid 41541458)
216. Wen XQ, Li X-J, Su Z-L et al.: Reduced expression of a-tocopherol- associated protein is associated with tumor cell proliferation and the increased risk of prostate cancer recurrence. Asian J. Androl. 9, 206-212 (2007). (Pubitemid 46416581)
217. Kempná P, Zingg J-M, Ricciarelli R et al.: Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. Free Radic. Biol. Med. 34, 1458-1472 (2003). (Pubitemid 36570418)
218. Bortner JD, Das A, Umstead TM et al.: Down-regulation of 14-13-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysis. J. Proteome Res. 8, 4050-4061 (2009).
219. Miehe S, Bieberstein A, Arnould I et al.: The phospholipid-binding protein SESTD1 is a novel regulator of the transient receptor potential channels TRPC4 and TRPC5. J. Biol. Chem. 285, 12426-12434 (2010).
220. Bezzerides VJ, Ramsey IS, Kotecha S, Greka A, Clapham DE: Rapid vesicular translocation and insertion of TRP channels. Nat. Cell Biol. 6, 709-720 (2004). (Pubitemid 39144476)
221. Hong SK, Levin C, Brown J et al.: Pregastrula expression of zebrafish extraembryonic genes. BMC Develop. Biol. 10, 42 (2010).
222. The Scripps Research Institute - Mutagenetix home page http://mutagenetix.scripps.edu/home.cfm